Home / Journals / ECN / Vol.22, No.3, 2011
Special Issues
  • Open AccessOpen Access

    REVIEW

    IL-37: a new anti-inflammatory cytokine of the IL-1 family

    Diana Boraschi1, Davide Lucchesi1, Stefan Hainzl2, Maria Leitner2, Elisabeth Maier2, Doris Mangelberger2, Gertie J. Oostingh2, Tobias Pfaller2, Claudia Pixner2, Gernot Posselt2, Paola Italiani1, Marcel F. Nold3,4, Claudia A. Nold-Petry3,4, Philip Bufler5, Charles A. Dinarello3
    European Cytokine Network, Vol.22, No.3, pp. 127-47, 2011, DOI:10.1684/ecn.2011.0288
    Abstract The IL-1 family of cytokines encompasses eleven proteins that each share a similar β-barrel structure and bind to Ig-like receptors. Some of the IL-1-like cytokines have been well characterised, and play key roles in the development and regulation of inflammation. Indeed, IL-1α (IL-1F1), IL-1β (IL-1F2), and IL-18 (IL-1F4) are well-known inflammatory cytokines active in the initiation of the inflammatory reaction and in driving Th1 and Th17 inflammatory responses. In contrast, IL-1 receptor antagonist (IL-1Ra, IL-1F3) and the receptor antagonist binding to IL-1Rrp2 (IL-36Ra, IL-1F5) reduce inflammation by blocking the binding of the agonist receptor ligands.… More >

  • Open AccessOpen Access

    REVIEW

    Langerhans cell histiocytosis: a cytokine/chemokine-mediated disorder?

    Lara Garabedian1, Sofie Struyf2, Ghislain Opdenakker2, Silvano Sozzani3, Jo Van Damme2, Geneviève Laureys1
    European Cytokine Network, Vol.22, No.3, pp. 148-153, 2011, DOI:10.1684/ecn.2011.0290
    Abstract Langerhans cell histiocytosis (LCH) is a rare disorder characterized by an abnormal accumulation and/or proliferation of cells with a Langerhans cell phenotype. Although no clear cause of LCH has been identified, it has been postulated that LCH might be the consequence of an immune dysregulation, causing Langerhans cells to migrate to and accumulate at various sites. Production of cytokines and chemokines is a central feature of immune regulation. Cytokines are abundantly present within LCH lesions. We review here the potential role of cytokines and chemokines in the pathogenesis of LCH. The type, distribution, and number More >

  • Open AccessOpen Access

    ARTICLE

    Contribution of VEGF polymorphisms to variation in VEGF serum levels in a healthy population

    Heba H. Al-Habboubi, Mai S. Sater, Ahmad W. Almawi, Ghada M. Al-Khateeb, Wassim Y. Almawi
    European Cytokine Network, Vol.22, No.3, pp. 154-158, 2011, DOI:10.1684/ecn.2011.0289
    Abstract Objective. Vascular endothelial growth factor (VEGF) is a pro-angiogenic factor. Variability in VEGF expression, induced by specific VEGFA variants, are involved in angiogenesis-related disorders. This study examined the genotype distribution and functional role (VEGF expression) of rs699947, rs833061, rs1570360, rs2010963, rs833068, rs833070, rs3025020, and rs3025039 VEGFA variants and their haplotypes in 519 healthy Bahraini individuals of both genders. Methods and results. The distribution of the eight VEGFA polymorphisms screened was in Hardy-Weinberg equilibrium. The minor allele frequencies of rs699947 (0.42), rs833061 (0.32), rs1570360 (0.31), rs2010963 (0.33), rs833068 (0.37), rs833070 (0.42), rs3025020 (0.33), and rs3025039 (0.13)… More >

  • Open AccessOpen Access

    ERRATUM

    ERRATUM


    European Cytokine Network, Vol.22, No.3, pp. 159-159, 2011
    Abstract This article has no abstract. More >

Per Page:

Share Link